A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaques
P. Harris, T. Brasel, C. Massey, C. Herst, S. Burkholz, P. Lloyd, T. Blankenberg, T. Bey, R. Carback, T. Hodge, S. Ciotlos, L. Wang, J. E. Comer, R. M. Rubsamen
A synthetic peptide vaccine targeting SARS-CoV-2 nucleocapsid protein protected rhesus macaques from viral challenge, reducing pneumonia and viral load.
bioRxiv · Apr 24, 2021Immunology